Archive Newsletter

1. 04.06.26 -- February 2026 — CDMO Opportunities And Threats Report 4/6/2026
   04/06/26 Cell & Gene Newsletter
2. 04.03.26 -- Zymeworks Shares Its Design Rationale (And Wins) In Early-Phase ADC Trials 4/3/2026
   04/03/26 Cell & Gene Newsletter
3. 04.02.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing 4/2/2026
   04/02/26 Cell & Gene Newsletter
4. 04.01.26 -- The In Vivo Cell Therapy Shift On Display At PMWC 2026 4/1/2026
   04/01/26 Cell & Gene Newsletter
5. 03.31.26 -- STREAM Edition: Take The Lead With A GS Cell Line Development Kit 3/31/2026

   03/31/26 Cell & Gene Newsletter

6. 03.31.26 -- UK's Decentralized Manufacturing Could Be A Revolution; Mind The Risk 3/31/2026
   03/31/26 Cell & Gene Newsletter
7. 03.30.26 -- The Long Road To U.S. Vaccine Manufacturing 3/30/2026
   03/30/26 Cell & Gene Newsletter
8. 03.27.26 -- Accelerating Technology Diffusion In Cell And Gene Therapy 3/27/2026
   03/27/26 Cell & Gene Newsletter
9. 03.26.26 -- The Hidden Obstacles Stalling Advanced Therapies 3/26/2026

   03/26/26 Cell & Gene Newsletter

10. 03.26.26 -- FDA's 483 Playbook: What It Means And Misses For Pharma Outsourcing 3/26/2026
    03/26/26 Cell & Gene Newsletter